UK Biocentre: From Scaling During COVID-19 to Supporting the Next Generation of Therapeutics

UK Biocentre is a respected leader in sample management, high-capacity bioprocessing & analysis, and automated storage.
With the capacity to store 35 million individual sample, it is the main processor for many of the UK’s government genetics projects, including the ambitious Our Future Health project which aims to collect and analyse the genetic samples of 5 million residents.
We sat down with Dr Tony Cox OBE a molecular biologist and CEO of UK Biocentre to discuss the centre’s pivotal role during the COVID-19 pandemic, and how they have returned to supporting ambitious biopharmaceutical projects.
“I’ve always been fascinated by DNA and the concept of information moving between generations. It blows my mind that something as simple but as complex could have arisen,” says Dr Cox. “We have a vibrant life science sector in the UK. It’s a fantastic place to be doing genetics."




Read the full article